Sorafenib and Vorinostat in Treating Patients With Advanced Liver Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01075113
Recruitment Status : Active, not recruiting
First Posted : February 24, 2010
Last Update Posted : September 12, 2017
Massey Cancer Center
Information provided by (Responsible Party):
Virginia Commonwealth University

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : February 2, 2017
  Estimated Study Completion Date : January 31, 2023